Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Down 90.5% in April

Nihon Kohden Corporation (OTCMKTS:NHNKY – Get Free Report) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 21,619 shares, a decrease of 90.5% from the April 15th total of 226,933 shares. Based on an average daily volume of 54,689 shares, the short-interest ratio is currently 0.4 days. Currently, 0.0% of the company’s stock are short sold.

Wall Street Analysts Forecast Growth

NHNKY has been the topic of a number of recent research reports. Zacks Research upgraded Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. UBS Group raised shares of Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy”.

Get Nihon Kohden alerts:

Get Our Latest Report on Nihon Kohden

Nihon Kohden Price Performance

NHNKY traded down $0.22 on Tuesday, reaching $9.05. The company’s stock had a trading volume of 8,376 shares, compared to its average volume of 30,446. Nihon Kohden has a 1 year low of $8.93 and a 1 year high of $14.21. The business’s 50 day moving average is $9.58 and its 200 day moving average is $10.60. The stock has a market cap of $1.55 billion, a price-to-earnings ratio of 17.75 and a beta of 0.41.

Nihon Kohden Company Profile

(Get Free Report)

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.

See Also

• Five stocks we like better than Nihon Kohden
• The Event That Could Redefine Apple’s Summer Rally
• Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
• Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?
• Shake Shack Stock Gets Shaken After Earnings Miss

Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.